Home » Topics » Regulatory

Regulatory
RSS

Scopolamine gel available in U.S. for motion sickness

April 26, 1996

U.S. government claims new antipsychotic compositions

April 26, 1996

Prograf approved for new indication in Japan, launched in France

April 26, 1996

MitoExtra enters clinical trials

April 26, 1996

Hyal-CT1101 effective in phase III trial

April 26, 1996

FDA approves Prilosec + Biaxin combination for H. pylori

April 19, 1996

Zanidip approved for marketing in U.K.

April 19, 1996

FDA approves new indication for Pravachol

April 19, 1996

Vaqta gets the green light from FDA

April 12, 1996

Improved Havrix approved by FDA

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...